Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...
Patent
1993-03-29
1994-10-11
Cintins, Marianne M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Nitrogen containing other than solely as a nitrogen in an...
A61K 31135
Patent
active
053547802
ABSTRACT:
A method of therapeutically administering certain BZ.sub.1 specific trifluorobenzodiazepines in order to maximize the BZ.sub.1 effects and minimize the BZ.sub.2 effects on the human central nervous system in order to maximize the anti-anxiety, anticonvulsant and hypnotic effects and minimize the ataxic and incoordination effects of the drug. Also, a method of sublingual administration of trifluorobenzodiazepines and certain other compounds in order to decrease unwanted dealkylated metabolites.
REFERENCES:
patent: 2728779 (1955-12-01), Pohland et al.
patent: 3972995 (1976-08-01), Tsuk et al.
patent: 5198436 (1993-03-01), Ellinwood, Jr. et al.
Ellinwood Everett H.
Gupta Samir K.
Cintins Marianne M.
Criares T. J.
Jenkins Richard E.
LandOfFree
Intraoral dosing method of administering (+)-.alpha.-4-(dimethyl does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Intraoral dosing method of administering (+)-.alpha.-4-(dimethyl, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Intraoral dosing method of administering (+)-.alpha.-4-(dimethyl will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1658905